TSNLF

Tristel PLC

Healthcare · $276M market cap

Verdict

We can't put a fair value on TSNLF right now.

Business quality

4 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth12.0% a year✓
Equity per share growth7.2% a year✗
Sales growth12.7% a year✓
Free cash flow growth14.4% a year✓
Return on invested capital17.3%✓

Follow TSNLF

Track it on your watchlist and see the full analysis. Free.

Create a free account

Questions about TSNLF

How can I check TSNLF's value myself?

Use the free Sticker Price calculator, already filled with TSNLF's numbers. Change the growth, P/E or required return and see what you'd pay. Open the calculator →

Similar stocks · Medical - Instruments & Supplies

About Tristel PLC

Operating both within the United Kingdom and globally, Tristel plc specializes in the development, production, and distribution of products designed for infection control. Its business is structured into three primary divisions: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and a third, unnamed 'Other' segment. Under its proprietary Tristel brand, the firm provides a comprehensive range of medical instrument disinfection solutions. These cater to a diverse array of applications, such as airway management, cardiology, ENT, endoscopy, gastrointestinal physiology, laboratory use, ophthalmology, phlebotomy, reproductive health/IVF, surface disinfection, ultrasound, urology, and women's health, alongside other related offerings. Established in 1993, Tristel plc maintains its headquarters in Snailwell, United Kingdom.

Medical - Instruments & Supplies

Fair value and Payback Price are estimates from the company's reported financials, not investment advice. How the Payback Price works